[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Oncologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

 


Chair
Maha H. A. Hussain, M.D.

Expertise:  Hematology, Oncology
Term:  7/1/2004 - 6/30/2008
Professor of Medicine and Urology
Department of Internal Medicine and Urology
Division of Hematology/Oncology
University of Michigan
7314 CGCG, 1500 E. Medical Center Drive
Ann Arbor, Michigan 48109

Designated Federal Official
Nicole Vesely, Pharm.D., R.Ph.
Advisors and Consultants Staff (HFD-21)
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland, 20857
(301) 827-7001, Fax: (301) 827-6776
e-mail: Nicole.Vesely@fda.hhs.gov

Ronald M. Bukowski, M.D.
Expertise:  Hematology, Oncology
Term:  7/1/2004 - 6/30/2008
Director
Experimental Therapeutics Program
The Cleveland Clinic Foundation
One Clinic Center
9500 Euclid Avenue
Cleveland, Ohio 44195

S. Gail Eckhardt, M.D.
Expertise: Medical Oncology
Term: 2/26/2006 - 6/30/2009
Director, Division of Medical Oncology
GI Malignancies Program
University of Colorado Health Sciences Center
12801 E. 17th Avenue
Aurora, Colorado 80010

David Harrington, Ph.D.
Expertise: Statistics
Term: 3/8/2006 - 6/30/2009
Department of Biostatistics and Computational Biology
Dana-Farber Cancer Institute
44 Binney Street
Boston, Massachusetts 02115

Michael Link, M.D.
Expertise: Pediatric Oncology
Term: 11/15/2006 - 6/30/2010
The Lydia J. Lee Professor of Pediatrics
Chief, Division of Hematology/Oncology
Stanford University School of Medicine
1000 Welch Road, Suite 300
Palo Alto, California 94304

Gary H. Lyman, M.D. M.P.H., FRCP (Edin)
Expertise: Med.Onc/Hem, Biostats/Epidem
Term: 2/26/2007 - 6/30/2010
Director
Health Services and Outcomes Research Program-Oncology
Duke University Medical Center
Box 3645
Durham, NC 27710

*Virginia P. Mason, R.N.
Expertise: Oncology Nursing
Term: 7/1/2007 - 6/30/2011
Executive Director
Inflammatory Breast Cancer Research Foundation
P.O. Box 786
Citronelle, AL 36522

Joanne E. Mortimer, M.D. F.A.C.P.
Expertise:  Breast Cancer, Medical Oncology
Term:  7/8/2004 - 6/30/2008
Vice Chair Medical Oncology
City of Hope Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010

Michael C. Perry, M.D.
Expertise:  Hematology, Oncology
Term:  7/8/2004 - 6/30/2008
Director
Division of Hematology/Medical Oncology
University of Missouri
Ellis Fischel Cancer Center
115 Business Loop 70 West
Columbia, Missouri 65203

Ronald Richardson, M.D.
Term: 3/8/2007 – 6/30/2010
Expertise: Medical Oncology
Consultant
Department of Medical Oncology
Mayo Clinic
200 First Street, S.W., Gonda 10
Rochester, MN 55905


PDF requires the free Adobe Acrobat Reader

* Consumer Representative
** Industry Representative, non voting

Back to Top      
  Back to Oncologic Drugs Advisory Committee Info
  Human Drug Advisory Committee Information

Date created: July 22, 2003, Updated: January 15, 2007

horizonal rule